EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Short-term Investments (2011 - 2026)

EyePoint (EYPT) posted Short-term Investments of $144.8 million for Q1 2026, down 29.1% sequentially from $204.3 million in Q4 2025, and down 37.85% YoY from $233.0 million in Q1 2025.

Analysis

EyePoint (EYPT) Short-term Investments (2011 - 2026) Analysis & Trends

EyePoint has reported Short-term Investments for 13 years, with the latest figure at $144.8 million in Q1 2026.

  • Quarterly Short-term Investments fell 37.85% year-over-year to $144.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $144.8 million (down 37.85% YoY) and the FY2025 annual result came in at $204.3 million, down 24.68% from the prior year.
  • Short-term Investments eased to $144.8 million in Q1 2026 per EYPT's latest filing, from $204.3 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $271.2 million in Q4 2024 and troughed at $2.9 million in Q2 2023.
  • A 5-year average of $114.2 million and a median of $89.2 million in 2022 frame the typical range for Short-term Investments.
  • The sharpest annual moves came in 2023 and 2024: Short-term Investments slumped 96.74% in 2023, then soared 6433.76% in 2024.
  • Over 5 years, Short-term Investments stood at $48.9 million in 2022, then gained by 1.76% to $49.8 million in 2023, then surged by 444.74% to $271.2 million in 2024, then retreated by 24.68% to $204.3 million in 2025, then retreated by 29.1% to $144.8 million in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods registered $144.8 million, $204.3 million, and $129.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.01 Mn
Mar 31, 2026 144.83 Mn
Dec 31, 2025 204.27 Mn
Sep 30, 2025 129.45 Mn
Jun 30, 2025 184.59 Mn
Mar 31, 2025 233.04 Mn
Dec 31, 2024 271.21 Mn
Sep 30, 2024 173.96 Mn
Jun 30, 2024 189.48 Mn
Mar 31, 2024 28.34 Mn
Dec 31, 2023 49.79 Mn
Sep 30, 2023 3.00 Mn
Jun 30, 2023 2.94 Mn
Mar 31, 2023 16.72 Mn
Dec 31, 2022 48.93 Mn
Sep 30, 2022 81.90 Mn
Jun 30, 2022 89.03 Mn
Mar 31, 2022 89.24 Mn
Dec 31, 2021 33.00 Mn
Mar 31, 2017 2.50 Mn